Chronic NKG2D Engagement In Vivo Differentially Impacts NK Cell Responsiveness by Activating NK Receptors

Area of Science:

• Immunology
• Cancer Biology
• Cellular Signaling

Background:

• Cancer-associated immunosuppression often involves the NKG2D receptor and other activating NK cell receptors.
• In vitro studies suggest chronic NKG2D engagement impairs NKG2D and other NK receptor function.

Purpose of the Study:

• To investigate the in vivo consequences of chronic NKG2D receptor engagement on other activating NK cell receptors.
• To analyze the functional impact on NKp46 and Ly49D receptors using a transgenic mouse model.

Main Methods:

• Utilized a transgenic mouse model (H2-K^b-MICA) with ubiquitous NKG2D ligand expression.
• Assessed NK cell receptor expression and function, specifically NKp46 and Ly49D, in vivo.
• Investigated the role of shared adaptor proteins (DAP10 and DAP12) in receptor signaling.

Main Results:

• Contrary to in vitro predictions, NKp46 expression and function were not impaired in H2-K^b-MICA mice.
• A significant downregulation and dysfunction of the Ly49D receptor were observed in activated NK cells.
• The shared adaptor proteins DAP10 and DAP12 between NKG2D and Ly49D may explain the observed Ly49D impairment.

Conclusions:

• Persistent NKG2D engagement in vivo selectively impairs unrelated NK receptors, specifically Ly49D.
• This impairment of Ly49D function compromises overall NK cell responsiveness to non-self antigens.
• Findings highlight a novel mechanism of immune evasion in the tumor microenvironment.